The present invention is directed to compound of formula (A): ##STR00001## wherein R.sub.1 is selected from (a) alkyl, alkenyl, alkynyl, cycloalkyl, aryl, and heteroaryl, or (b) CN and --C(NR.sub.10R.sub.11).dbd.N--R.sub.12, R.sub.2 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl, R.sub.3-R.sub.12 are as described within the specification, and A is O, NR.sub.9 or S, or a prodrug, a pharmaceutically acceptable salt or a pharmaceutically active metabolite thereof, provided that R.sub.1 is not alkyl when R.sub.2 is pyridine, provided that at least one of R.sub.3-R.sub.8 is not H or F when A is O, R.sub.1 is (b) and R.sub.2 is a phenyl ring, a phenyl ring substituted at the para position with halo, --CN, --OCH.sub.3, --CF.sub.3 or --CO.sub.2CH.sub.3, a quinoline or an ethylene substituted with a phenyl ring or a 3,4-methylenedioxyphenyl moiety, provided that R.sub.4 is not methyl when R.sub.3 and R.sub.5-R.sub.8 are H, A is O, R.sub.1 is (b) and R.sub.2 is 4-chlorophenyl, and provided that R.sub.6 is not Cl when R.sub.3-R.sub.5 and R.sub.7-R.sub.8 are H, R.sub.1 is CN and R.sub.2 is phenyl. This invention is also directed to methods of using the same for treating HIV infections, or AIDS, or preventing replication.

 
Web www.patentalert.com

< Expression of a recombinant transgene

> Antigen-binding polypeptides and their uses

> p-amidobenzylethers in drug delivery agents

~ 00529